In reply
We would like to thank Drs Mataftsi and Horgan for their interest in our article and their valuable remarks. As for the specific issues raised:
Because glaucoma is a slowly progressive chronic disease, it is widely accepted that any study evaluating a real effect on glaucoma patients should be extended for at least several years. However, as we all have learned to appreciate the importance of intraocular pressure (IOP) reduction in patients with glaucoma, we strongly believe that even an interim study of IOP response during a mean follow-up of 11 months is worth reporting.
Intraocular pressure was measured in our study by applanation tonometry. Two measurements were taken by the same ophthalmologist, 1 minute apart, and the average IOP value was calculated. All measurements were made between 9 AM and 10 AM, both prior to selective laser trabeculoplasty (SLT), and at all time intervals postoperatively.
Gonioscopy . . . [Full Text of this Article]
AUTHOR INFORMATION